Kardiochirurgia i Torakochirurgia Polska

Abstract

2/2024 vol. 21
Review paper

Proposal for the use of angiotensin II in distributive shock after extracorporeal circulation – position paper of the Section of Intensive Care Medicine and the Section of Cardiothoracic Anaesthesiology of the Polish Society of Anaesthesiology and Intensive Therapy

Łukasz J. Krzych 1, 2, 3, 4, 5
,
Paweł Nadziakiewicz 1, 4, 5
,
Ewa Kucewicz-Czech 1, 5
  1. Department of Anaesthesiology and Intensive Care, Silesian Centre for Heart Diseases, Zabrze, Poland
  2. Department of Acute Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  3. Section of Intensive Care Medicine, Polish Society of Anaesthesiology and Intensive Therapy
  4. Department of Cardiac Anaesthesiology and Intensive Care, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
  5. Section of Cardiothoracic Anaesthesiology, Polish Society of Anaesthesiology and Intensive Therapy
Kardiochirurgia i Torakochirurgia Polska 2024; 21 (2): 96-98
DOI: https://doi.org/10.5114/kitp.2024.141146
Online publish date: 2024/07/07
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Angiotensin II (AT) is a potent vasoconstrictor and hypertensive drug that is registered for the treatment of severe hypotension in vasoplegic shock. Growing experience with the use of AT in cardiac surgery allows the first therapeutic algorithms to be created. This paper is a proposal for the use of AT in distributive shock after extracorporeal circulation.

Keywords

distributive shock, extracorporeal circulation, angiotensin II, treatment

Share
without publication fees
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
plagiat pl
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications